Drug Action & Cellular Targets – Comprehensive Study Notes

Foundational Overview

  • Drugs interact with specific molecular structures ("cellular targets") to alter physiological functions.
    • Major target families: enzymes (e.g., \text{COX}), receptors (e.g., 5\text{-HT}, \text{CB}_1), and structural proteins (e.g., bacterial PBPs).
    • Understanding the mechanism of action (MOA) bridges molecular changes → tissue responses → visible clinical outcomes.
  • Two broad therapeutic groups discussed:
    1. Analgesic/antipyretic & anti-inflammatory agents (human-enzyme targets).
    2. Antibiotics (pathogen-specific cell-wall targets).
  • Ethical / practical link to previous lectures:
    • Builds on pharmacodynamics concepts (agonist vs. inhibitor).
    • Reinforces antimicrobial-stewardship principles to curb resistance.

Analgesic & Antipyretic — Paracetamol (Acetaminophen)

Generic & Brand Names

  • Generic: Paracetamol (a.k.a. Acetaminophen)
  • Representative brand: Biogesic
  • Tablet strength often presented as 500\ \text{mg}

Drug Class & Core Uses

  • Classified as an analgesic and antipyretic (non-opioid).
  • Relieves mild–moderate pain (e.g., headaches) & lowers fever from viral infections (colds, flu).

Key Cellular Targets

  • Predominantly inhibits cyclo-oxygenase enzymes in CNS:
    • Brain-specific splice variant sometimes labeled COX-3.
  • Second-tier interactions via its active metabolite AM404 with:
    • 5\text{-HT}_{1A/2A} serotonin receptors.
    • \text{CB}_1 cannabinoid receptors.
    • \text{TRPV1} vanilloid receptors.

Detailed Mechanism (stepwise)

  1. COX blockade → ↓ \text{PGE}_2 synthesis.
  2. Enhanced descending serotonergic signaling from mid-brain → spinal cord = endogenous pain gate control.
  3. AM404 prevents anandamide re-uptake → indirect agonism of \text{CB}_1 & stimulation of \text{TRPV1}.
  4. Net neuronal membrane stabilization → ↓ excitability for pain & thermoregulatory pathways.

Why Central Targeting Matters

  • Peripheral inflamed tissues contain high peroxide concentrations that render paracetamol’s COX inhibition ineffective.
  • Central action achieves analgesia & antipyresis without significant peripheral anti-inflammatory effect—explains why swelling is unchanged.

Cellular → Tissue Cascade

  • ↓ Prostaglandins + neurotransmitter modulation → less firing of nociceptive neurons in brain/spinal cord.
  • Hypothalamic temperature set-point falls → fever resolution.

Primary Tissues Affected

  • Central nervous system (brain + spinal cord).
  • Negligible activity in peripheral inflamed tissue.

Observable Clinical Changes

  • Subjective pain relief, reduced body temperature.
  • No redness/swelling reduction—key differentiator from NSAIDs.

Therapeutic Pearls

  • First-line for pediatric fevers & patients with gastric ulcer risk (lacks COX-1 gastric toxicity).

Potential Side Effects / Toxicity

  • Hepatotoxicity at overdoses > 4\;\text{g/day} (NAPQI metabolite accumulation) → acute liver failure.
  • Rare allergic reactions; nephrotoxicity in chronic high doses.

Nursing Actions & Interventions

  • Monitor total daily intake (consider combination cold remedies).
  • Educate on max dose, alcohol avoidance (adds hepatic burden).
  • Assess AST/ALT, creatinine if prolonged therapy.

Non-Steroidal Anti-Inflammatory Drug — Ibuprofen

Generic & Brands

  • Generic: Ibuprofen
  • Common brands: Advil, Motrin, Midol (e.g., 200\;\text{mg} caplets)

Drug Class & Uses

  • NSAID; treats mild–moderate pain, inflammatory states, fever, arthritis.

Specific Cellular Targets

  • Reversibly binds COX-1 & COX-2 inside cells → blocks arachidonic-acid conversion to prostaglandins & thromboxanes.

Stepwise Mechanism

  1. Lipid-soluble molecule crosses cell membrane.

  2. Occupies COX catalytic site (competitive inhibition).

  3. ↓ \text{PGs} → ↓ pain, ↓ vasodilation, ↓ platelet \text{TXA}_2 (mild anti-clot effect).

    \text{Arachidonic Acid} \xrightarrow[\text{blocked}]{\text{COX-1/2}} \text{PGH}2 \to \text{PGE}2/\text{PGI}2/\text{TXA}2

Rationale for Target

  • COX products orchestrate cardinal signs of inflammation; inhibiting them blunts the entire cascade.

Cellular → Tissue Impact

  • ↓ Capillary permeability & vasodilation → less edema and warmth.
  • Desensitized nociceptors → pain relief.
  • Hypothalamic PG reduction → antipyresis.

Tissues Most Affected

  • Inflamed joints/muscles, hypothalamus, GI mucosa (COX-1 protective loss), kidneys (renal blood-flow PGs).

Observable Outcomes

  • Decreased swelling, stiffness, body temp.
  • Potential gastric irritation, renal fluid-retention, ↑ BP with chronic use.

Therapeutic Highlights

  • Cornerstone drug for musculoskeletal pain & dysmenorrhea when swelling present.

Potential Side Effects

  • GI ulcer/bleed, dyspepsia, light-headedness.
  • Renal impairment (↓ GFR), edema, allergic bronchospasm in ASA-sensitive asthma.

Nursing Considerations

  • Give with food/milk; avoid on empty stomach.
  • Monitor BP, BUN/Creatinine, CBC (occult bleed).
  • Contra-indicated in GI ulcer history, renal failure, third-trimester pregnancy.

Non-Selective NSAID — Mefenamic Acid

Generic & Presentation

  • Mefenamic Acid 250\;\text{mg} film-coated tablets (e.g., RiteMED®)

Drug Class & Main Uses

  • NSAID, particularly effective for dysmenorrhea, mild–moderate pain, fever.

Cellular Targets & Mechanism

  • Non-selectively inhibits COX-1 & COX-2 ☞ ↓ prostaglandins.
  • Resultant ↓ uterine \text{PGF}_{2\alpha} → diminished smooth-muscle contractions.
  • General anti-inflammatory pathway mirrors ibuprofen.
  • Uterus: ↓ cramp intensity & duration.
  • Inflamed joints/muscles: ↓ redness, swelling, pain.
  • GI mucosa & kidneys susceptible because of COX-1 inhibition.

Therapeutic Edge

  • Preferred when uterine cramping is predominant symptom.

Side Effects / Risks

  • Gastric irritation, black/tarry stools, vomiting blood (ulceration).
  • Renal stress in long-term high-dose users.
  • Classic NSAID allergy issues (angioedema, asthma exacerbation).

Nursing Focus

  • Pre-assess NSAID allergy, renal baseline.
  • Administer with meals; advise hydration & avoidance of alcohol/NSAID stacking.
  • Teach early reporting of GI bleed signs.

Penicillin Antibiotic — Amoxicillin

Generic & Brand

  • Generic: Amoxicillin
  • Example brand: Himox (tablets 1000\;\text{mg})

Drug Class & Indications

  • Beta-lactam (penicillin) antibiotic.
  • Infections: pneumonia, ENT, UTI, skin/soft tissue.

Specific Bacterial Targets

  • Binds bacterial Penicillin-Binding Proteins (PBPs) required for peptidoglycan cross-linking.

Mechanism of Action

  1. Beta-lactam ring resembles D!-!Ala!-!D!-!Ala terminus.
  2. Irreversibly acylates transpeptidase active site.
  3. No cross-linking → weak wall → osmotic lysis.

Selectivity Explanation

  • Human cells lack cell wall → minimal direct toxicity.

Cellular → Tissue Response

  • Drug absorbed (oral) in small intestine → plasma → penetrates infected tissue.
  • Bactericidal action ↓ pathogen load → ↓ inflammatory cytokines → symptom relief.

Primary Tissues Affected

  • Any infected tissue (respiratory, urinary, skin, ENT).

Observable Clinical Changes

  • ↓ fever, swelling, purulent discharge.

Therapeutic Points

  • Broad spectrum vs. Gram-positives and some Gram-negatives.

Side Effects

  • Hypersensitivity (rash → anaphylaxis).
  • GI upset, diarrhea from gut flora disturbance.

Nursing Duties

  • Verify allergy history (cross-reactivity within beta-lactams).
  • Stress completing full course to prevent resistance.
  • Monitor for rash, severe diarrhea (possible C.\ difficile colitis).

Cephalosporin Antibiotic — Cephalexin

Generic & Brands

  • Cephalexin (Keflex, Biocef, Daxbia) 500\;\text{mg} capsules.

Drug Class & Uses

  • First-generation cephalosporin (beta-lactam) for UTIs, skin, bone, respiratory, and surgical prophylaxis.

Cellular Targets & MOA

  • Same fundamental action as penicillins:
    • Binds PBPs → blocks transpeptidation → peptidoglycan collapse → lysis.
  • Often more stable vs. certain beta-lactamases than amoxicillin.

Selectivity & Rationale

  • Attacks bacterial-exclusive structures → sparing host cells.

Cellular → Tissue Effects

  • Systemic distribution post-absorption; eradicates bacteria at infection site.
  • Prophylactic dosing pre-op reduces surgical-site infection risk.

Tissues Affected

  • Skin, urinary tract, respiratory tract, bone.

Observable Outcomes

  • ↓ erythema, drainage, pain; normalization of WBC count.

Side Effects

  • Rash, pruritus, swelling.
  • GI upset; alteration of microbiome → risk of C.\ difficile or vaginal candidiasis.

Nursing Management

  • Give with light meal to curb nausea.
  • Warn against self-medicating with other drugs (possible interference or duplicate therapy).
  • Observe for allergy or severe diarrhea; advise hydration.

Cross-Drug Comparative Notes

  • COX Inhibition Spectrum:
    • Paracetamol: CNS-selective, minimal anti-inflammatory.
    • Ibuprofen / Mefenamic Acid: systemic; both COX-1 & COX-2.
  • Adverse-Effect Trade-offs:
    • Paracetamol safer on stomach/kidneys but hepatotoxic at OD.
    • NSAIDs risk GI bleed, renal impairment; ceiling dose often \le 1200\;\text{mg/day} (OTC ibuprofen).
  • Beta-Lactam Family Comparisons:
    • Penicillins vs. Cephalosporins: similar MOA; partial cross-allergy (~10\%).
  • Ethical / Stewardship Angle:
    • Overuse of antibiotics → resistance; nurses educate on finishing course & not demanding antibiotics for viral illnesses.
    • NSAID over-the-counter availability necessitates patient literacy on proper dosing.

Quick Reference Equations & Values

  • Maximum OTC paracetamol daily dose (adult): dose_{max}=4000\;\text{mg}
  • Ibuprofen anti-inflammatory dose range: 600!\text{–}!800\;\text{mg} q8h (prescription strength).
  • Simplified prostaglandin pathway:
    \text{AA} \xrightarrow{COX} \text{PGH}2 \to \begin{cases} \text{PGE}2 & \text{pain/fever}\
    \text{PGI}2 & \text{vasodilation}\ \text{TXA}2 & \text{platelet aggregation}
    \end{cases}

Practical Memory Aids / Mnemonics

  • "Para-CENTRAL" = Paracetamol acts centrally.
  • "I BUy PROs-staglandins" – Ibuprofen buys time by blocking prostaglandins.
  • "MEfenamic for MEnstrual cramps" – drug of choice for dysmenorrhea.
  • "A-MOX-wall-illin" – amoxicillin knocks out the wall.
  • "**Ceph-a-lexin = Ceph" (first syllable) *protects* skin & UTIs lexin (less intense than later gens).

Red-Flag Assessment Checklist (All Drugs)

  • Allergies ✔
  • Baseline renal & liver function ✔
  • GI history (ulcers, bleeding) ✔
  • Concomitant meds (warfarin, methotrexate, other NSAIDs, OCs with antibiotics) ✔

High-Yield Exam Tips

  • Distinguish analgesic vs. anti-inflammatory properties of paracetamol.
  • Relate NSAID GI risk to COX-1 inhibition of gastric PGs.
  • Recall beta-lactam MOA as PBP inhibition → no cross-linking.
  • Justify antibiotic selectivity: human cells lack peptidoglycan.
  • Emphasize nursing role in dose monitoring & patient education to prevent toxicity and resistance.